2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$6.77-$0.06 (-0.81%)
Price as of Aug 21, 2026 7:30 PM EDT- $149.3MMarket Cap
- -30.19%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$6.77-$0.06 (-0.81%)
AARD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.82 | ||
Change | +$0.93 (+15.79%) | ||
Open | $5.91 | ||
High | $6.90 | ||
Low | $5.80 | ||
Previous Close | $5.89 | ||
Volume | 173,693 | ||
30-Day Average Volume | 133,112 | ||
1-Week Change | 4.28% | ||
1-Month Change | 12.17% | ||
1-Year Change | -30.19% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.9M | ||
Total Assets | $81.5M | ||
Market Cap | $149.3M | ||
Enterprise Value | $75.4M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$14.4M | ||
EBITDA | -$14.4M | ||
Net Working Capital | $74.3M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 37,703 | ||
P/B | 2 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 07/21/2008 | ||
Earnings & Revenue